AMLX
AMLX
NASDAQ · Pharmaceuticals

Amylyx Pharmaceuticals Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks
$22.82
-1.37 (-5.66%)
As of Aug 8, 10:08 PM ET ·
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 15 88%
Hold 2 12%
Sell 0 0%
Price Target
Analyst Price Target +62.8% upside
Low Target $28.49
Average Target $37.15
High Target $49.81
Current Price $22.82
Current
$22.82
Target
$37.15
$28.49 $37.15 avg $49.81
Scenario Analysis
Bear Case
$28.49
24.8%
Low target
Base Case
$37.15
+62.8%
Avg target
Bull Case
$49.81
+118.3%
High target
Risk/Reward
4.8x
Highly favorable
Price in Context
52-Week High
$24.36
-6.3% from high
52-Week Low
$7.48
+205.1% from low
Target vs 52W High
$37.15
+52.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
 Strong Sell 45 31% — +0.0%
JNJ
Johnson & Johnson
 Buy 31 71% $299.55 +15.5%
MRK
Merck & Co. Inc.
 Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
 Hold 36 39% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
 Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
 Hold 24 54% $209.87 +188.8%